Samsung Biologics Signs Contract With Global Pharma Company
Samsung Biologics signed a contract to manufacture products for a global pharmaceutical company.
Related stories
Sellas Life Sciences Shares Fall 12% to $8.55, Hit One-Month Low
Sellas Life Sciences shares fell 12% to $8.55 on Monday, their lowest level in more than a month. Disclosures showed several investment firms increased their third-quarter holdings
M impact | EQUITY | Nov 03, 2026, 01:22 AM UTC
L&F Signs Cathode Supply Deal With LG Energy Solution
L&F signed a long-term supply contract for LFP cathode active materials with LG Energy Solution and its subsidiary on Nov. 2, 2026.
M impact | EQUITY | Nov 03, 2026, 01:13 AM UTC
L&F Signs $774 Million Battery Materials Supply Deal With LG Energy Solution
L&F signed a battery materials supply deal with LG Energy Solution valued at USD 774 million.
M impact | EQUITY | Nov 03, 2026, 01:13 AM UTC
BH Co. Q3 Operating Profit Falls 11.5% to 30.5 Billion Won
BH Co. reported third-quarter operating profit of 30.5 billion won, down 11.5% from a year earlier.
M impact | EQUITY | Nov 03, 2026, 01:08 AM UTC
L&F Wins Won Order for LFP Cathode Supply
L&F Co Ltd says it won an order to supply LFP cathode.
M impact | EQUITY | Nov 03, 2026, 01:08 AM UTC
Citizens Holding Company Announces Third-Quarter Results
M impact | EQUITY | Nov 03, 2026, 01:08 AM UTC